Pathological and molecular aspects of prostate cancer
Top Cited Papers
- 1 March 2003
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 361 (9361), 955-964
- https://doi.org/10.1016/s0140-6736(03)12779-1
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- Hereditary prostate cancerAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
- RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer casesNature Genetics, 2002
- Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic LocalizationJournal of Biological Chemistry, 2002
- P504S: A New Molecular Marker for the Detection of Prostate CarcinomaJournal of Urology, 2002
- Methylation and Inactivation of Estrogen, Progesterone, and Androgen Receptors in Prostate CancerJNCI Journal of the National Cancer Institute, 2002
- A Population-Based Study of Daily Nonsteroidal Anti-inflammatory Drug Use and Prostate CancerMayo Clinic Proceedings, 2002
- Role of Macrophage Scavenger Receptors in Response to Listeria monocytogenes Infection in MiceThe American Journal of Pathology, 2001
- Interobserver reproducibility of Gleason grading of prostatic carcinoma: General pathologistHuman Pathology, 2001
- A gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapyCancer, 1998
- Clinical and Cost Impact of Second-opinion PathologyThe American Journal of Surgical Pathology, 1996